NCT06108947View on ClinicalTrials.gov

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

NARecruitingINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions

Pre-Eclampsia

Interventions

DRUG

Aspirin

Aspirin discontinuation

Trial Locations (1)

Unknown

RECRUITING

St. Olavs hospital, Trondheim

All Listed Sponsors

lead

St. Olavs Hospital

OTHER